APPLICATION
ANDA070082
TYPE
ANDA
ORIGINAL APPROVAL
1986-10-29
LATEST ACTION
2016-08-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
FUROSEMIDEDiscontinued
FUROSEMIDE 80MG · TABLET · ORAL
Approval history
2016-08-01Labeling · Supplement 27 · standardAP
2016-08-01Labeling · Supplement 28 · standardAP
2008-11-04Labeling · Supplement 22AP
2001-10-22Manufacturing (CMC) · Supplement 17AP
2001-10-22Manufacturing (CMC) · Supplement 16AP
1998-12-07Manufacturing (CMC) · Supplement 15AP
1998-02-05Manufacturing (CMC) · Supplement 14AP
1997-10-06Labeling · Supplement 13AP
1996-04-24Labeling · Supplement 12AP
1994-01-07Manufacturing (CMC) · Supplement 11AP
1993-06-15Labeling · Supplement 10AP
1993-04-13Labeling · Supplement 8AP
1992-05-06Labeling · Supplement 7AP
1992-03-18Labeling · Supplement 6AP
1990-12-27Labeling · Supplement 5AP
1990-05-03Labeling · Supplement 4AP
1990-02-16Labeling · Supplement 2AP
1990-01-31Manufacturing (CMC) · Supplement 3AP
1988-06-10Manufacturing (CMC) · Supplement 1AP
1986-10-29OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.